While the mechanism is plausible, the evidence does not yet exist to say what it does in people, at what dose, for what problem, or in which populations, especially in women
[2] [3] The tiredness experienced by some patients likely reflects both direct medication effects and indirect consequences of the medication's therapeutic actions on appetite, food intake, and metabolism
Patients with established hypertension should have blood pressure measured at baseline and at each dose escalation (typically every 4 weeks during titration), then every 36 months once stabilised
The comparison below is a research-framing summary, not a ranking of effectiveness
Tirzepatides dual agonist function targets both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor
For extra nutritional help during treatment, the GLP-1 Daily Support supplement is designed to fit alongside a GLP-1 routine